Whitener Capital Management Inc. Sells 100 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Whitener Capital Management Inc. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,239 shares of the medical equipment provider’s stock after selling 100 shares during the quarter. Whitener Capital Management Inc.’s holdings in Intuitive Surgical were worth $1,791,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. RB Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 4.4% in the 1st quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock worth $523,000 after acquiring an additional 73 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in Intuitive Surgical by 0.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider’s stock worth $285,603,000 after purchasing an additional 5,233 shares during the period. Baird Financial Group Inc. lifted its stake in Intuitive Surgical by 2.3% in the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider’s stock worth $6,362,000 after purchasing an additional 481 shares during the last quarter. Brown Brothers Harriman & Co. grew its stake in shares of Intuitive Surgical by 576.7% during the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 346 shares during the last quarter. Finally, Covestor Ltd raised its holdings in shares of Intuitive Surgical by 50.4% in the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock worth $126,000 after buying an additional 140 shares during the period. 82.91% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.3 %

Shares of ISRG stock traded up $0.93 during trading hours on Tuesday, reaching $299.10. 443,028 shares of the company’s stock were exchanged, compared to its average volume of 1,694,909. Intuitive Surgical, Inc. has a 1 year low of $180.07 and a 1 year high of $358.07. The stock has a market cap of $105.10 billion, a PE ratio of 74.73, a PEG ratio of 4.15 and a beta of 1.30. The stock’s fifty day moving average price is $314.56 and its two-hundred day moving average price is $298.07.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $1.42 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.09. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Intuitive Surgical had a return on equity of 12.41% and a net margin of 21.38%. The company’s revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.85 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 4.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Raymond James boosted their price target on Intuitive Surgical from $323.00 to $368.00 and gave the company an “outperform” rating in a report on Monday, July 24th. Mizuho increased their price target on Intuitive Surgical from $300.00 to $370.00 in a research report on Monday, July 17th. Piper Sandler lifted their price objective on Intuitive Surgical from $315.00 to $385.00 and gave the company an “overweight” rating in a report on Friday, July 21st. Sanford C. Bernstein increased their target price on shares of Intuitive Surgical from $350.00 to $365.00 in a report on Wednesday, May 31st. Finally, JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $335.00 to $365.00 and gave the company an “overweight” rating in a research report on Friday, July 21st. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $343.10.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 2,535 shares of the stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $323.26, for a total transaction of $819,464.10. Following the sale, the executive vice president now directly owns 7,259 shares of the company’s stock, valued at $2,346,544.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Gary S. Guthart sold 4,960 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $325.89, for a total transaction of $1,616,414.40. Following the completion of the transaction, the chief executive officer now directly owns 32,320 shares of the company’s stock, valued at approximately $10,532,764.80. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 2,535 shares of the stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $323.26, for a total value of $819,464.10. Following the transaction, the executive vice president now owns 7,259 shares in the company, valued at approximately $2,346,544.34. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 60,309 shares of company stock worth $19,649,321. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.